Veranex Accelerating Clinical Trials with Veeva Vault CDMS
Global medtech CRO gains agility to build studies in-house and make mid-study amendments faster
Veeva Systems announced that Veranex is using Veeva Vault CDMS to speed study builds and simplify clinical data management. The global contract research organization (CRO) can use Vault CDMS for electronic data capture (EDC), coding, and data cleaning. Vault CDMS enables their study teams to build complex studies quickly, migrate trials from other solutions, and make mid-study changes with zero downtime.
Top NLP Update: Natural Language Processing: The Technology That’s Biased
“Veeva’s innovative technology and industry expertise make it the ideal partner to help us tackle the demands of highly complex studies,” said Richard Murg, senior vice president, business development at Veranex. “Veeva Vault CDMS delivers advanced capabilities that are easy-to-use, significantly streamlining our database builds and improving collaboration with clients.”
Veranex serves the medical technology industry by providing design, engineering, regulatory, preclinical research, clinical development, commercial strategy, and market access services. By modernizing clinical data management with Vault CDMS, Veranex has a scalable system that can accelerate the development and execution of high-quality trials.
AI and ML News: AI: Continuing the Chase for Brain-Level Efficiency
“Bringing together Veranex’s experience addressing the toughest challenges in data management with the flexibility of Veeva Vault CDMS is a recipe for effective clinical studies,” said Manny Vazquez, director, Veeva Vault Clinical strategy. “We are happy to support their efforts to transform clinical data management for seamless processes that can accelerate the development of novel medical products.”
AI ML in Marketing: AI and Big Data Analysis Used to Find Brands’ Emotional Connection
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.